Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac vs Ketorolac for Miosis Prevention in Cataract Surgery
NCT03851172Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, single-blind trial in miosis comparing Nepafenac + Cyclopentolate, Ketorolac + Cyclopentolate and Placebo + Cyclopentolate (3 arms). Primary endpoint: Prevention of miosis during cataract surgery at 30 minutes. Status: unknown.
02
Drugs
nepafenacketorolac tromethamine
03
Conditions
miosis
Beyond the preview
Go deeper on NCT03851172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03851172.